Biden's effort to reclassify marijuana is a smart move
Biden's efforts to change marijuana from a Schedule I drug to a Schedule III drug is good for marijuana research, public safety and business.
Stay updated with breaking news from Controlled Substances. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biden's efforts to change marijuana from a Schedule I drug to a Schedule III drug is good for marijuana research, public safety and business.
President Joe Biden has been accused of yet another election year ploy to appeal to younger voters with his historic move to reclassify marijuana as a less dangerous drug.
Investors are taking profits on marijuana stocks today, but the long-term trend still looks up.
The DEA proposal to move marijuana to a Schedule III drug could give sweeping tax breaks to pot businesses.
WASHINGTON (AP) — The U.S. Drug Enforcement Administration is moving toward reclassifying marijuana as a less dangerous drug. The Justice Department proposal would recognize the medical uses of cannabis but wouldn’t legalize it for recreational use. The proposal still faces a potentially lengthy review process, but if is approved it could have wide-ranging effects. It could make marijuana research easier. It could reduce taxes for legal cannabis businesses. Some advocates for legalized weed say the move doesn't go far enough, while opponents say it goes too far.